Literature DB >> 11468356

The structure of apo protein-tyrosine phosphatase 1B C215S mutant: more than just an S --> O change.

G Scapin1, S Patel, V Patel, B Kennedy, E Asante-Appiah.   

Abstract

Protein-tyrosine phosphatases catalyze the hydrolysis of phosphate monoesters via a two-step mechanism involving a covalent phospho-enzyme intermediate. Biochemical and site-directed mutagenesis experiments show that the invariant Cys residue present in the PTPase signature motif (H/V)CX(5)R(S/T) (i.e., C215 in PTP1B) is absolutely required for activity. Mutation of the invariant Cys to Ser results in a catalytically inactive enzyme, which still is capable of binding substrates and inhibitors. Although it often is assumed that substrate-trapping mutants such as the C215S retain, in solution, the structural and binding properties of wild-type PTPases, significant differences have been found in the few studies that have addressed this issue, suggesting that the mutation may lead to structural/conformational alterations in or near the PTP1B binding site. Several crystal structures of apo-WT PTP1B, and of WT- and C215S-mutant PTP1B in complex with different ligands are available, but no structure of the apo-PTP1B C215S has ever been reported. In all previously reported structures, residues of the PTPase signature motif have an identical conformation, while residues of the WPD loop (a surface loop which includes the catalytic Asp) assume a different conformation in the presence or absence of ligand. These observations led to the hypothesis that the different spectroscopic and thermodynamic properties of the mutant protein may be the result of a different conformation for the WPD loop. We report here the structure of the apo-PTP1B C215S mutant, which reveals that, while the WPD loop is in the open conformation observed in the apo WT enzyme crystal structure, the residues of the PTPases signature motif are in a dramatically different conformation. These results provide a structural basis for the differences in spectroscopic properties and thermodynamic parameters in inhibitor binding observed for the wild-type and mutant enzymes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11468356      PMCID: PMC2374080          DOI: 10.1110/ps.11001

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  46 in total

1.  Structure-based design of a low molecular weight, nonphosphorus, nonpeptide, and highly selective inhibitor of protein-tyrosine phosphatase 1B.

Authors:  L F Iversen; H S Andersen; S Branner; S B Mortensen; G H Peters; K Norris; O H Olsen; C B Jeppesen; B F Lundt; W Ripka; K B Møller; N P Møller
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

2.  The CCP4 suite: programs for protein crystallography.

Authors: 
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1994-09-01

3.  Molecular basis for the dephosphorylation of the activation segment of the insulin receptor by protein tyrosine phosphatase 1B.

Authors:  A Salmeen; J N Andersen; M P Myers; N K Tonks; D Barford
Journal:  Mol Cell       Date:  2000-12       Impact factor: 17.970

4.  2-(oxalylamino)-benzoic acid is a general, competitive inhibitor of protein-tyrosine phosphatases.

Authors:  H S Andersen; L F Iversen; C B Jeppesen; S Branner; K Norris; H B Rasmussen; K B Møller; N P Møller
Journal:  J Biol Chem       Date:  2000-03-10       Impact factor: 5.157

Review 5.  Protein tyrosine phosphatases: a diverse family of intracellular and transmembrane enzymes.

Authors:  E H Fischer; H Charbonneau; N K Tonks
Journal:  Science       Date:  1991-07-26       Impact factor: 47.728

6.  Thermodynamic study of ligand binding to protein-tyrosine phosphatase 1B and its substrate-trapping mutants.

Authors:  Y L Zhang; Z J Yao; M Sarmiento; L Wu; T R Burke; Z Y Zhang
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

7.  Structural basis of plasticity in protein tyrosine phosphatase 1B substrate recognition.

Authors:  M Sarmiento; Y A Puius; S W Vetter; Y F Keng; L Wu; Y Zhao; D S Lawrence; S C Almo; Z Y Zhang
Journal:  Biochemistry       Date:  2000-07-18       Impact factor: 3.162

8.  X-ray crystal structure and characterization of halide-binding sites of human myeloperoxidase at 1.8 A resolution.

Authors:  T J Fiedler; C A Davey; R E Fenna
Journal:  J Biol Chem       Date:  2000-04-21       Impact factor: 5.157

9.  Evidence for protein-tyrosine-phosphatase catalysis proceeding via a cysteine-phosphate intermediate.

Authors:  K L Guan; J E Dixon
Journal:  J Biol Chem       Date:  1991-09-15       Impact factor: 5.157

10.  Hydrogen bonds involving sulfur atoms in proteins.

Authors:  L M Gregoret; S D Rader; R J Fletterick; F E Cohen
Journal:  Proteins       Date:  1991
View more
  10 in total

1.  Dynamics of the WPD loop of the Yersinia protein tyrosine phosphatase.

Authors:  Xin Hu; C Erec Stebbins
Journal:  Biophys J       Date:  2006-05-12       Impact factor: 4.033

2.  ¹H, ¹³C and ¹⁵N backbone and side-chain resonance assignments of Drosophila melanogaster Ssu72.

Authors:  Jon W Werner-Allen; Pei Zhou
Journal:  Biomol NMR Assign       Date:  2011-07-06       Impact factor: 0.746

3.  Free-energy profiles for catalysis by dual-specificity phosphatases.

Authors:  Guilherme M Arantes
Journal:  Biochem J       Date:  2006-10-15       Impact factor: 3.857

4.  Direct Intracellular Delivery of Benzene Diazonium Ions As Observed by Increased Tyrosine Phosphorylation.

Authors:  Natasha R Cornejo; Bismark Amofah; Austin Lipinski; Paul R Langlais; Indraneel Ghosh; John C Jewett
Journal:  Biochemistry       Date:  2022-03-18       Impact factor: 3.321

Review 5.  Cryo-EM for Small Molecules Discovery, Design, Understanding, and Application.

Authors:  Giovanna Scapin; Clinton S Potter; Bridget Carragher
Journal:  Cell Chem Biol       Date:  2018-08-09       Impact factor: 8.116

6.  Identification of ligand binding sites of proteins using the Gaussian Network Model.

Authors:  Ceren Tuzmen; Burak Erman
Journal:  PLoS One       Date:  2011-01-25       Impact factor: 3.240

7.  New potential eukaryotic substrates of the mycobacterial protein tyrosine phosphatase PtpA: hints of a bacterial modulation of macrophage bioenergetics state.

Authors:  Mariana Margenat; Anne-Marie Labandera; Magdalena Gil; Federico Carrion; Marcela Purificação; Guilherme Razzera; María Magdalena Portela; Gonzalo Obal; Hernán Terenzi; Otto Pritsch; Rosario Durán; Ana María Ferreira; Andrea Villarino
Journal:  Sci Rep       Date:  2015-03-06       Impact factor: 4.379

Review 8.  Why Antidiabetic Vanadium Complexes are Not in the Pipeline of "Big Pharma" Drug Research? A Critical Review.

Authors:  Thomas Scior; Jose Antonio Guevara-Garcia; Quoc-Tuan Do; Philippe Bernard; Stefan Laufer
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

9.  Mechanism of activating mutations and allosteric drug inhibition of the phosphatase SHP2.

Authors:  Ricardo A P Pádua; Yizhi Sun; Ingrid Marko; Warintra Pitsawong; John B Stiller; Renee Otten; Dorothee Kern
Journal:  Nat Commun       Date:  2018-10-30       Impact factor: 14.919

10.  Docosahexaenoic Acid Inhibits PTP1B Phosphatase and the Viability of MCF-7 Breast Cancer Cells.

Authors:  Alicja Kuban-Jankowska; Magdalena Gorska-Ponikowska; Kamlesh Kumar Sahu; Tomasz Kostrzewa; Michal Wozniak; Jack Tuszynski
Journal:  Nutrients       Date:  2019-10-23       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.